Oncology Trends: The latest innovations in cancer care - Prime Therapeutics
Oncology Trends: The latest innovations in cancer care
Recent webinar featuring Prime Therapeutics experts shares some of the latest breakthrough therapies — including ADCs, BiTes and CAR-T treatments — and regulatory changes and market shifts that are guiding the future of cancer treatment
The oncology landscape is evolving at an unprecedented pace — from breakthrough therapies and precision medicine to artificial intelligence (AI)-driven care and new models for patient experience.
In the latest Oncology Trends webinar, “Future-ready oncology: Innovations shaping tomorrow,” Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal, and Dina Elberjawi, PharmD, BCPS, senior director of specialty clinical solutions, discuss some of the latest trends, technologies and strategies that are redefining cancer care, including:
Emerging therapies. Learn about the newest treatment modalities, including antibody drug conjugates (ADCs), bi-specific T-cell engagers (BiTes) and chimeric antigen receptor (CAR) T-cell therapies.
Regulatory changes and market shifts. Shifts in the U.S. Food and Drug Administration (FDA)’s processes have potential impacts on market dynamics and site eligibility.
Pipeline and strategic planning. Panelists share the importance of proactive planning for the expanding oncology pipeline, including forecasting, operational preparation and outcomes-based contracting.
Real-world impact. Listen to clinical leaders discuss the practical implications of these innovations for patients, payers and the broader health care ecosystem.
“We need strong data infrastructure and the ability to capture outcomes, track total cost of care and support evidence-driven contracting decisions,” Elberjawi said. “At Prime, we’re continually monitoring these frameworks to support our client’s goal, and that as innovation accelerates, we maintain a strong balance between access, affordability and quality of care. In short, proactive planning helps us stay ahead of the oncology curve.”
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.